2024 World Conference on Lung Cancer (WCLC) - Posters-P4.17E.01 Navigating from Target to Treatment: Early Impact of the Lung Precision Oncology Navigation Program (LPOP)

P4.17E.01 Navigating from Target to Treatment: Early Impact of the Lung Precision Oncology Navigation Program (LPOP)

Pdf Summary

The Lung Precision Oncology Navigation Program (LPOP) at the Princess Margaret Cancer Centre significantly improved the management and treatment of patients with non-squamous non-small cell lung cancer (NSCLC). With the introduction of LPOP, the program aimed to enhance access to precision medicine by ensuring patients had timely and complete molecular testing, which is critical for making informed treatment decisions.<br /><br />Key objectives of the LPOP included increasing the availability of biomarker results by the time of the initial oncology consultation and ensuring complete genotyping. Following the implementation of LPOP, there was a notable increase in patients having complete genotyping results at their first consultation, rising from 66.9% pre-LPOP to 78.5% post-LPOP.<br /><br />Despite improvements, challenges remained, particularly concerning the delays and incompleteness of results from external laboratories. To further address these issues, the program recommends better coordination with labs, streamlining the genotyping process, and implementing a tracking system to ensure timely and comprehensive results.<br /><br />The program also emphasized enhancements in the workflow to improve clinical trial matching, leading to more effective personalized treatment plans. Healthcare providers became more familiar with the role of the LPOP navigator, who played a key role in coordinating results and recommending trial matches and targeted therapies.<br /><br />Future directions include expanding the LPOP to other hospital networks and creating educational resources for patient advocacy groups, thus broadening the program's reach and impact. Overall, LPOP demonstrates a promising model for improving efficiency and access to personalized cancer treatment through better navigation and coordination of molecular testing.

Asset Subtitle

Nadia Ghazali

Meta Tag

Speaker Nadia Ghazali

Topic Global Health, Health Services & Health Economics

Keywords

Lung Precision Oncology Navigation Program

Princess Margaret Cancer Centre

non-squamous non-small cell lung cancer

precision medicine

molecular testing

biomarker results

genotyping

clinical trial matching

personalized treatment

patient advocacy